FAP and cancer: FAP-targeted NIR-PIT was more effective in immunocompetent mice than in athymic mice, suggesting that this therapy has both direct anti-cancer effects but also depends on activating the immune response by decreasing Tregs and increasing cytotoxic T cells in the TME.